ArrowFast, a medical device software, and solution provider is helping Positrigo develop a compact brain positron emission tomography (PET) scanner.
The new PET scanner ‘NeuroLF’ will be used for efficient, low-cost early detection of brain diseases, such as Alzheimer’s Disease. PET scanners make it possible to provide patients an evaluation of the risk to develop Alzheimer’s Disease more than 10 years before the symptoms appear.
Dr. Jannis Fischer, Positrigo CEO, said: “We were looking for a imaging medical device specialist with the capabilities to help us deliver a very complex medical product, comprising Electronics and Software, without compromising for quality, safety, and performance. We chose Cosylab’s ArrowFast for their track-record in medical device systems, their broad skill set in radio-oncology, and their battle-tested medically compliant development processes. We are confident that in a partnership with ArrowFast we can bring our PET scanner to the patients faster.”
Igor Rogelj, the head of ArrowFast, added: “We are honoured to be chosen by Positrigo as their technology partner. Venturelab positioned them as one of the 10 Swiss medtech start-ups to watch in 2020, and Drs. Jannis and Ahnen were on the Forbes list “30 under 30” in Science and Healthcare 2018. They also received the prestigious EIC Accelerator grant. It is our privilege to be entrusted to participate in a project with a potential to disrupt medical imaging.”
